67 related articles for article (PubMed ID: 20578240)
1. PML down-regulation in soft tissue sarcomas.
Vincenzi B; Perrone G; Santini D; Grosso F; Silletta M; Frezza A; Rossi S; Russo A; Rabitti C; Gebbia N; Badalamenti G; Casali P; Muda AO; Dei Tos AP; Tonini G
J Cell Physiol; 2010 Sep; 224(3):644-8. PubMed ID: 20578240
[TBL] [Abstract][Full Text] [Related]
2. PML expression in soft tissue sarcoma: prognostic and predictive value in alkylating agents/antracycline-based first line therapy.
Vincenzi B; Santini D; Schiavon G; Frezza AM; Silletta M; Crucitti P; Casali P; Dei Tos AP; Rossi S; Rizzo S; Badalamenti G; Tomasino RM; Russo A; Butrynski JE; Tonini G
J Cell Physiol; 2012 Apr; 227(4):1657-62. PubMed ID: 21678421
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of promyelocytic leukemia body in soft tissue sarcomas.
Matsuo T; Sugita T; Shimose S; Kubo T; Ishikawa M; Yasunaga Y; Ochi M
J Exp Clin Cancer Res; 2008 Nov; 27(1):73. PubMed ID: 19025608
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues.
Gambacorta M; Flenghi L; Fagioli M; Pileri S; Leoncini L; Bigerna B; Pacini R; Tanci LN; Pasqualucci L; Ascani S; Mencarelli A; Liso A; Pelicci PG; Falini B
Am J Pathol; 1996 Dec; 149(6):2023-35. PubMed ID: 8952536
[TBL] [Abstract][Full Text] [Related]
5. Promyelocytic leukemia (PML) nuclear bodies are disorganized in colorectal tumors with total loss of major histocompatibility complex class I expression and LMP7 downregulation.
Cabrera CM; Jiménez P; Concha A; Garrido F; Ruiz-Cabello F
Tissue Antigens; 2004 May; 63(5):446-52. PubMed ID: 15104675
[TBL] [Abstract][Full Text] [Related]
6. Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner.
Haupt S; Mitchell C; Corneille V; Shortt J; Fox S; Pandolfi PP; Castillo-Martin M; Bonal DM; Cordon-Cardo C; Lozano G; Haupt Y
Cell Cycle; 2013 Jun; 12(11):1722-31. PubMed ID: 23656786
[TBL] [Abstract][Full Text] [Related]
7. Loss of p16(INK4a) is associated with reduced patient survival in soft tissue tumours, and indicates a senescence barrier.
Knösel T; Altendorf-Hofmann A; Lindner L; Issels R; Hermeking H; Schuebbe G; Gibis S; Siemens H; Kampmann E; Kirchner T
J Clin Pathol; 2014 Jul; 67(7):592-8. PubMed ID: 24747207
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of promyelocytic leukemia (PML) protein expression in preeclamptic placentae.
Leavenworth JD; Groesch KA; Xin Hu ; Malm S; Torry RJ; Abrams R; Torry DS
Reprod Sci; 2010 Apr; 17(4):339-49. PubMed ID: 20228380
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
[TBL] [Abstract][Full Text] [Related]
10. Loss of promyelocytic leukemia protein in human gastric cancers.
Lee HE; Jee CD; Kim MA; Lee HS; Lee YM; Lee BL; Kim WH
Cancer Lett; 2007 Mar; 247(1):103-9. PubMed ID: 16713073
[TBL] [Abstract][Full Text] [Related]
11. PML and TRF2 protein expression in hereditary and sporadic colon cancer.
Plevová P; Bouchal J; Fiurásková M; Papezová M; Krepelová A; Curík R; Foretová L; Navrátilová M; Zapletalová J; Posolda T; Kolár Z
Neoplasma; 2007; 54(4):269-77. PubMed ID: 17822315
[TBL] [Abstract][Full Text] [Related]
12. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
[TBL] [Abstract][Full Text] [Related]
13. The comparative role of immunohistochemistry and electron microscopy in the identification of myogenic differentiation in soft tissue pleomorphic sarcomas.
Franchi A; Massi D; Santucci M
Ultrastruct Pathol; 2005; 29(3-4):295-304. PubMed ID: 16036884
[TBL] [Abstract][Full Text] [Related]
14. Concordant expression of proto-oncogene promyelocytic leukemia and major histocompatibility antigen HLA class I in human hepatocellular carcinoma.
Xia M; Zhang JQ; Shen YQ; Xu LH; Chen AQ; Miao FQ; Xie W
Tissue Antigens; 2007 Oct; 70(4):272-82. PubMed ID: 17767548
[TBL] [Abstract][Full Text] [Related]
15. SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma.
Kohashi K; Oda Y; Yamamoto H; Tamiya S; Oshiro Y; Izumi T; Taguchi T; Tsuneyoshi M
Am J Surg Pathol; 2008 Aug; 32(8):1168-74. PubMed ID: 18580682
[TBL] [Abstract][Full Text] [Related]
16. Selective activation of NFAT by promyelocytic leukemia protein.
Lo YH; Wu CC; Shih HM; Lai MZ
Oncogene; 2008 Jun; 27(27):3821-30. PubMed ID: 18246125
[TBL] [Abstract][Full Text] [Related]
17. Cell-cycle regulation and dynamics of cytoplasmic compartments containing the promyelocytic leukemia protein and nucleoporins.
Jul-Larsen A; Grudic A; Bjerkvig R; Bøe SO
J Cell Sci; 2009 Apr; 122(Pt 8):1201-10. PubMed ID: 19339552
[TBL] [Abstract][Full Text] [Related]
18. [Expression of PML in carcinogenesis of laryngocarcinoma and nasopharyngeal carcinoma].
Chen W; Yao W; Chen S; Xiao B; Tao Z
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Feb; 21(3):128-31. PubMed ID: 17441430
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase expression in high grade soft tissue sarcomas.
Alford SH; Vrana MS; Waite L; Heim-Hall J; Sylvia VL; Williams RP
Oncol Rep; 2007 Dec; 18(6):1529-36. PubMed ID: 17982640
[TBL] [Abstract][Full Text] [Related]
20. [Expression of promyelocytic leukaemia protein in lung carcinomas and clinical significance thereof].
Zhao ZL; Huang QY; Xu S; Zhang L; Zhao HR
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(47):3362-6. PubMed ID: 17313836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]